SCHEMBL16947129

SCHEMBL16947129

c1ccc(-c2ccc(N(c3cccc(-c4ccc(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)cc4)c3)c3cccc4ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ TSPO P30536 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ SIGMAR1 Q99720 3/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ F2 P00734 1/20 0.31
▸ F10 P00742 1/20 0.31
▸ PRSS1 P07477 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17056424 1.00 L3MBTL1 (0.41) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL19383179 0.99 L3MBTL1 (0.40) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL16947146 0.99 L3MBTL1 (0.42) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL18310205 0.98 KDM4E (0.38) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL16947133 0.98 KDM4E (0.38) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL17250380 0.98 L3MBTL1 (0.43) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL17250132 0.97 L3MBTL1 (0.42) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL19738282 0.97 L3MBTL1 (0.42) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL19533760 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMRXRARXRB
SCHEMBL19383181 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMRXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012212-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012212-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-01-12 — — US disclosed
WO-2015111888-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2015-07-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012212-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, PIEZO1 L3MBTL1 297/4885KDM4E 984/4885ATM 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback